Study to Evaluate the Long-Term Safety, Tolerability, and Biological Activity of ATYR1940 in Patients With Limb Girdle and Facioscapulohumeral Muscular Dystrophy
Conditions: Facioscapulohumeral Muscular Dystrophy; Limb Girdle Muscular Dystrophy
Intervention: Drug: ATYR1940
Sponsor: aTyr Pharma, Inc.
Enrolling by invitation - verified December 2016
Intervention: Drug: ATYR1940
Sponsor: aTyr Pharma, Inc.
Enrolling by invitation - verified December 2016
News Type: